Trial of the Safety and Efficacy of Ozarelix in Participants With Benign Prostatic Hyperplasia (BPH)

NCT00743184 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Benign Prostatic Hyperplasia (BPH)
Lower Urinary Tract Symptoms (LUTS)

Interventions

DRUG: ozarelix
DRUG: Placebo

Sponsor

Spectrum Pharmaceuticals, Inc